Navidea Biopharmaceuticals, Inc. (NAVB)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 65.65 Thousand | 531.51 Thousand | 915.01 Thousand | 26.61 Thousand | 322.52 Thousand | 1.81 Million |
| Cost of Revenue | 184.94 Thousand | 198.83 Thousand | 1048.00 | 6667.00 | 96.63 Thousand | 3651.00 |
| Gross Profit | -119.29 Thousand | 332.67 Thousand | 913.96 Thousand | 19.95 Thousand | 225.88 Thousand | 1.8 Million |
| Operating Expenses | 13.93 Million | 12.59 Million | 11.62 Million | 10.98 Million | 11.07 Million | 15.68 Million |
| Selling, General and Administrative Expenses | 7.96 Million | 7.45 Million | 6.69 Million | 6.27 Million | 7.69 Million | 11.16 Million |
| Research and Development Expenses | 5.96 Million | 5.14 Million | 4.93 Million | 5.33 Million | 4.22 Million | 4.51 Million |
| Other Expenses | - | -14.11 Thousand | -21.85 Thousand | -631.2 Thousand | 1145.00 | - |
| Cost and Expenses | 14.11 Million | 12.59 Million | 11.62 Million | 10.98 Million | 11.16 Million | 15.68 Million |
| Operating Income | -14.05 Million | -12.06 Million | -10.71 Million | -10.96 Million | -10.84 Million | -13.87 Million |
| Interest Expense | 1.09 Million | 6361.00 | - | 25.28 Thousand | 30.79 Thousand | 168.97 Thousand |
| Income Tax Expense | - | 16.04 Thousand | -81.73 Thousand | 707.00 | 2747.00 | -4.06 Million |
| Earnings before Tax | -15.17 Million | -11.71 Million | -10.72 Million | -10.94 Million | -16.16 Million | -17.78 Million |
| Net Income | -15.17 Million | -11.73 Million | -10.63 Million | -10.94 Million | -16.12 Million | 74.94 Million |
| Earnings Per Share Basic | -0.59 | -0.40 | -0.45 | -0.76 | -1.89 | 9.40 |
| Earnings Per Share Diluted | -0.56 | -0.40 | -0.45 | -0.76 | -1.89 | 9.00 |
| Weighted Average Shares Outstanding | 29.34 Million | 29.34 Million | 23.89 Million | 14.39 Million | 8.52 Million | 8.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.9 Million | 29.34 Million | 23.89 Million | 14.39 Million | 8.52 Million | 8.3 Million |
| Gross Margin | -1.82 | 0.63 | 1.00 | 0.75 | 0.70 | 1.00 |
| EBIT Margin | -211.34 | -23.38 | -11.71 | -411.85 | -17.23 | -5.41 |
| Profit Margin | -231.18 | -22.07 | -11.63 | -411.21 | -50.00 | 41.40 |
| EBITDA | -13.87 Million | -11.5 Million | -10.64 Million | -10.81 Million | -10.84 Million | -13.14 Million |
| Earnings Before Tax Margin | -214.02 | -22.69 | -11.71 | -411.85 | -33.63 | -7.67 |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 65.65 Thousand | 610.00 | 7516.00 |
| Cost of Revenue | 36.03 Thousand | 36.37 Thousand | 36.55 Thousand | 184.94 Thousand | 50.03 Thousand | 134.43 Thousand |
| Gross Profit | -36.03 Thousand | -36.37 Thousand | -36.55 Thousand | -119.29 Thousand | -49.42 Thousand | -126.92 Thousand |
| Operating Expenses | 2.13 Million | 2.42 Million | 2.42 Million | 13.93 Million | 3.14 Million | 4.82 Million |
| Selling, General and Administrative Expenses | 1.3 Million | 1.32 Million | 1.15 Million | - | 1.25 Million | 3.63 Million |
| Research and Development Expenses | 829.61 Thousand | 1.1 Million | 1.26 Million | - | 1.89 Million | 1.18 Million |
| Other Expenses | -21.48 Thousand | -144.81 Thousand | 1.2 Million | -27.93 Thousand | -38.78 Thousand | 8422.00 |
| Cost and Expenses | 2.13 Million | 2.42 Million | 2.42 Million | 14.11 Million | 3.19 Million | 4.95 Million |
| Operating Income | -2.13 Million | -2.42 Million | -2.42 Million | -14.05 Million | -3.19 Million | -4.95 Million |
| Interest Expense | -102.51 Thousand | 614.38 Thousand | 263.19 Thousand | 1.09 Million | 1.86 Million | - |
| Income Tax Expense | 102.51 Thousand | -8.6 Million | -682.84 Thousand | 2.03 Million | 2.03 Million | 765.45 Thousand |
| Earnings before Tax | -2.25 Million | -1.39 Million | -1.47 Million | -15.17 Million | -3.48 Million | -5.7 Million |
| Net Income | -2.25 Million | 6.03 Million | -793.48 Thousand | -17.21 Million | -5.52 Million | -5.7 Million |
| Earnings Per Share Basic | -0.02 | 0.12 | -0.02 | - | -0.17 | -0.19 |
| Earnings Per Share Diluted | -0.02 | 0.12 | -0.02 | - | -0.17 | -0.19 |
| Weighted Average Shares Outstanding | 99.36 Million | 48.24 Million | 32.65 Million | 29.34 Million | 32.37 Million | 30.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 99.36 Million | 48.24 Million | 32.65 Million | 29.34 Million | 32.37 Million | 30.73 Million |
| Gross Margin | - | - | - | -1.82 | -81.03 | -16.89 |
| EBIT Margin | - | - | - | - | -5242.98 | -655.41 |
| Profit Margin | - | - | - | -262.22 | -9050.02 | -759.42 |
| EBITDA | -2.1 Million | -2.96 Million | -1.18 Million | - | -3.19 Million | -4.92 Million |
| Earnings Before Tax Margin | - | - | - | -214.02 | -5242.98 | -658.70 |
KAMDHENU
CAE
603388
7826
OCGN
SPARC